Catalyst Wire Dossier Catalyst Wire Dossier

Depigoid Birch

birch pollen allergoid · Leti Pharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Depigoid Birch, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]

See pricing